Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19.

Saved in:
Bibliographic Details
Title: Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19.
Authors: Schuster DJ; Center for Human Systems Immunology.; Department of Surgery, and.; Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA., Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Brackett C; Center for Human Systems Immunology.; Department of Surgery, and., Wesley M; Center for Human Systems Immunology.; Department of Surgery, and., Li SS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Eisel N; Center for Human Systems Immunology.; Department of Surgery, and., Tenney D; Center for Human Systems Immunology.; Department of Surgery, and., Hilliard S; Center for Human Systems Immunology.; Department of Surgery, and., Yates NL; Center for Human Systems Immunology.; Department of Surgery, and., Heptinstall JR; Center for Human Systems Immunology.; Department of Surgery, and., Williams LD; Center for Human Systems Immunology.; Department of Surgery, and., Shen X; Center for Human Systems Immunology.; Department of Surgery, and., Rolfe R; Center for Human Systems Immunology.; Department of Surgery, and.; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Cabello R; Asociación Civil Via Libre, Lima, Peru., Zhang L; Center for Human Systems Immunology.; Department of Surgery, and., Sawant S; Center for Human Systems Immunology.; Department of Surgery, and., Hu J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Randhawa AK; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Hyrien O; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Hural JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Frank I; Division of Infectious Disease, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Tomaras GD; Center for Human Systems Immunology.; Department of Surgery, and.; Department of Immunology, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA., Seaton KE; Center for Human Systems Immunology.; Department of Surgery, and.
Corporate Authors: HVTN 405/HPTN 1901 Study Team
Source: JCI insight [JCI Insight] 2022 Nov 08; Vol. 7 (21). Date of Electronic Publication: 2022 Nov 08.
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.158402